3:28 PM
 | 
Nov 27, 2013
 |  BC Extra  |  Company News

NICE wants more rifaximin data for hepatic encephalopathy

The U.K.'s NICE said it is "minded not to recommend" Targaxan rifaximin from Norgine B.V. (Amsterdam, the Netherlands) to reduce recurrence of episodes...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >